KRTAP2-1
gene geneOn this page
Also known as KAP2.1A
Summary
KRTAP2-1 (keratin associated protein 2-1, HGNC:16775) is a protein-coding gene on chromosome 17q21.2, encoding Keratin-associated protein 2-1 (Q9BYU5). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-link….
Predicted to be located in cytosol.
Source: NCBI Gene 81872 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 31 total
- MANE Select transcript:
NM_001123387
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16775 |
| Approved symbol | KRTAP2-1 |
| Name | keratin associated protein 2-1 |
| Location | 17q21.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KAP2.1A |
| Ensembl gene | ENSG00000212725 |
| Ensembl biotype | protein_coding |
| Entrez | 81872 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000391419
RefSeq mRNA: 1 — MANE Select: NM_001123387
NM_001123387
CCDS: CCDS42325
Canonical transcript exons
ENST00000391419 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001509201 | 41046541 | 41047316 |
Expression profiles
Bgee: expression breadth broad, 53 present calls, max score 45.10.
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of abdomen | UBERON:0001416 | 45.10 | gold quality |
| zone of skin | UBERON:0000014 | 42.50 | gold quality |
| right lung | UBERON:0002167 | 41.66 | gold quality |
| skin of leg | UBERON:0001511 | 41.02 | gold quality |
| sural nerve | UBERON:0015488 | 38.17 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| right uterine tube | UBERON:0001302 | 35.33 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| gastrocnemius | UBERON:0001388 | 30.55 | gold quality |
| muscle of leg | UBERON:0001383 | 30.52 | gold quality |
| blood | UBERON:0000178 | 30.44 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| heart left ventricle | UBERON:0002084 | 28.98 | gold quality |
| placenta | UBERON:0001987 | 28.80 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 27.71 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| popliteal artery | UBERON:0002250 | 27.49 | gold quality |
| kidney | UBERON:0002113 | 27.44 | gold quality |
| tibial artery | UBERON:0007610 | 27.32 | gold quality |
| heart | UBERON:0000948 | 27.28 | gold quality |
| cortex of kidney | UBERON:0001225 | 27.13 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.11 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting KRTAP2-1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-7112-5P | 99.59 | 65.76 | 104 |
| HSA-MIR-6832-5P | 99.58 | 64.82 | 1132 |
| HSA-MIR-4708-3P | 99.51 | 67.99 | 870 |
| HSA-MIR-103A-1-5P | 99.39 | 67.78 | 1545 |
| HSA-MIR-103A-2-5P | 99.39 | 67.72 | 1577 |
| HSA-MIR-3164 | 99.02 | 68.39 | 1071 |
| HSA-MIR-6820-3P | 99.02 | 68.50 | 1035 |
| HSA-MIR-3619-5P | 99.00 | 68.87 | 2308 |
| HSA-MIR-3926 | 98.95 | 69.26 | 1438 |
| HSA-MIR-6871-5P | 98.90 | 66.67 | 671 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-3922-5P | 98.77 | 66.53 | 1059 |
| HSA-MIR-4722-5P | 98.46 | 66.34 | 1611 |
| HSA-MIR-4773 | 98.35 | 67.30 | 1710 |
| HSA-MIR-499B-5P | 98.35 | 68.39 | 988 |
| HSA-MIR-5087 | 98.01 | 69.09 | 965 |
| HSA-MIR-9851-5P | 97.57 | 67.49 | 1067 |
| HSA-MIR-6855-5P | 97.51 | 66.03 | 830 |
| HSA-MIR-4296 | 96.35 | 63.55 | 1233 |
| HSA-MIR-6742-5P | 96.32 | 64.01 | 869 |
| HSA-MIR-4265 | 96.18 | 64.68 | 557 |
| HSA-MIR-4322 | 96.18 | 64.85 | 539 |
| HSA-MIR-3170 | 95.84 | 64.32 | 721 |
| HSA-MIR-6796-5P | 95.37 | 66.08 | 1120 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Krtap5-2 | ENSMUSG00000054759 |
| mus_musculus | Krtap5-20 | ENSMUSG00000056885 |
| mus_musculus | Krtap5-26 | ENSMUSG00000109859 |
| mus_musculus | Krtap5-24 | ENSMUSG00000110324 |
| rattus_norvegicus | Krtap5-8 | ENSRNOG00000020131 |
| rattus_norvegicus | AABR07006049.1 | ENSRNOG00000046649 |
Paralogs (47): KRTAP4-4 (ENSG00000171396), KRTAP9-7 (ENSG00000180386), KRTAP5-5 (ENSG00000185940), KRTAP12-1 (ENSG00000187175), KRTAP9-8 (ENSG00000187272), KRTAP10-8 (ENSG00000187766), KRTAP10-6 (ENSG00000188155), KRTAP1-1 (ENSG00000188581), KRTAP10-12 (ENSG00000189169), KRTAP4-3 (ENSG00000196156), KRTAP9-9 (ENSG00000198083), KRTAP4-6 (ENSG00000198090), KRTAP4-5 (ENSG00000198271), KRTAP4-1 (ENSG00000198443), KRTAP9-3 (ENSG00000204873), KRTAP4-8 (ENSG00000204880), KRTAP1-4 (ENSG00000204887), KRTAP12-3 (ENSG00000205439), KRTAP10-2 (ENSG00000205445), KRTAP5-6 (ENSG00000205864), KRTAP5-2 (ENSG00000205867), KRTAP16-1 (ENSG00000212657), KRTAP9-6 (ENSG00000212659), KRTAP4-11 (ENSG00000212721), KRTAP4-9 (ENSG00000212722), KRTAP2-3 (ENSG00000212724), KRTAP10-3 (ENSG00000212935), KRTAP4-12 (ENSG00000213416), KRTAP2-4 (ENSG00000213417), KRTAP2-2 (ENSG00000214518), KRTAP10-4 (ENSG00000215454), KRTAP10-1 (ENSG00000215455), KRTAP10-9 (ENSG00000221837), KRTAP1-5 (ENSG00000221852), KRTAP10-10 (ENSG00000221859), KRTAP12-2 (ENSG00000221864), KRTAP1-3 (ENSG00000221880), KRTAP9-2 (ENSG00000239886), KRTAP9-1 (ENSG00000240542), KRTAP4-7 (ENSG00000240871)
Protein
Protein identifiers
Keratin-associated protein 2-1 — Q9BYU5 (reviewed: Q9BYU5)
Alternative names: High sulfur keratin-associated protein 2.1, Keratin-associated protein 2.1
All UniProt accessions (1): Q9BYU5
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated proteins (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Similarity. Belongs to the KRTAP type 2 family.
RefSeq proteins (1): NP_001116859* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002494 | KAP | Family |
| IPR052154 | KRTAP_type_2-like | Family |
Pfam: PF01500
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9BYU5-F1 | 34.34 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
| R-HSA-1266738 | Developmental Biology |
MSigDB gene sets: 15 (showing top):
GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, GOCC_KERATIN_FILAMENT, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, BCAT_BILD_ET_AL_UP, E2F3_UP.V1_DN, MYC_UP.V1_DN, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MIR3145_3P, MIR4773, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP, GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP, chr17q21
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (3): cytosol (GO:0005829), keratin filament (GO:0045095), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
252 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KRTAP2-1 | KRTAP13-3 | Q3SY46 | 623 |
| KRTAP2-1 | KRTAP24-1 | Q3LI83 | 603 |
| KRTAP2-1 | ARHGEF33 | A8MVX0 | 545 |
| KRTAP2-1 | KRTAP1-4 | P0C5Y4 | 544 |
| KRTAP2-1 | FRMD1 | Q8N878 | 506 |
| KRTAP2-1 | SPRR4 | Q96PI1 | 500 |
| KRTAP2-1 | KRTAP3-2 | Q9BYR7 | 480 |
| KRTAP2-1 | KRTAP15-1 | Q3LI76 | 464 |
| KRTAP2-1 | KRTAP8-1 | Q8IUC2 | 447 |
| KRTAP2-1 | KRTAP11-1 | Q8IUC1 | 446 |
| KRTAP2-1 | PAGE1 | O75459 | 433 |
| KRTAP2-1 | RNF169 | Q8NCN4 | 423 |
| KRTAP2-1 | KRTAP3-1 | Q9BYR8 | 416 |
| KRTAP2-1 | DAOA | P59103 | 400 |
| KRTAP2-1 | DCLK3 | Q9C098 | 399 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A5A6P5, A6QP35, A8MTY7, A8MVA2, A8MXZ3, O75690, P02438, P02441, P02442, P02443, P08131, P0C7H8, P26371, P59990, P59991, P60014, P60331, P60368, P60369, P60370, P60371, P60372, P60409, P60410, P60411, P60412, P60413, Q05B44, Q07627, Q3V2C1, Q6L8G4, Q6L8G8, Q6L8G9, Q6L8H2, Q701N4, Q8IUG1, Q9BQ66, Q9BYP9, Q9BYQ0, Q9BYQ2
Diamond homologs: P02441, P02442, P02443, P0C7H8, Q9BYR9, Q9BYT5, Q9BYU5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
147 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:41047056:T:A | donor_gain | 0.9100 |
| 17:41047226:G:C | donor_gain | 0.6800 |
| 17:41047081:A:T | donor_gain | 0.6500 |
| 17:41046544:T:C | acceptor_gain | 0.6200 |
| 17:41046544:T:TC | acceptor_gain | 0.6200 |
| 17:41046895:T:TA | donor_gain | 0.5900 |
| 17:41047003:A:T | donor_gain | 0.5800 |
| 17:41046717:T:TC | acceptor_gain | 0.5700 |
| 17:41046884:G:C | donor_gain | 0.5600 |
| 17:41047219:C:A | donor_gain | 0.5600 |
| 17:41046717:T:C | acceptor_gain | 0.5500 |
| 17:41047085:C:CT | donor_gain | 0.5500 |
| 17:41047218:C:A | donor_gain | 0.5500 |
| 17:41046623:CAGA:C | donor_gain | 0.5300 |
| 17:41047086:G:T | donor_gain | 0.5300 |
| 17:41047082:C:T | donor_gain | 0.5200 |
| 17:41046954:TG:T | donor_gain | 0.5100 |
| 17:41047000:TGCA:T | donor_gain | 0.5100 |
| 17:41047006:C:CT | donor_gain | 0.5100 |
| 17:41046626:A:AC | donor_gain | 0.5000 |
| 17:41046627:C:CC | donor_gain | 0.5000 |
| 17:41046570:T:TC | acceptor_gain | 0.4900 |
| 17:41046594:T:C | donor_gain | 0.4500 |
| 17:41046616:T:TA | donor_gain | 0.4500 |
| 17:41046805:T:TA | donor_gain | 0.4500 |
| 17:41046553:C:CT | acceptor_gain | 0.4400 |
| 17:41046585:G:A | donor_gain | 0.4400 |
| 17:41046598:A:AC | donor_gain | 0.4400 |
| 17:41046629:T:TA | donor_gain | 0.4400 |
| 17:41046849:TG:T | donor_gain | 0.4400 |
AlphaMissense
814 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:41047003:A:G | C89R | 0.948 |
| 17:41047001:G:C | C89W | 0.929 |
| 17:41046986:C:A | W94C | 0.928 |
| 17:41046986:C:G | W94C | 0.928 |
| 17:41047033:A:G | C79R | 0.918 |
| 17:41047002:C:T | C89Y | 0.903 |
| 17:41047038:A:G | I77T | 0.903 |
| 17:41047038:A:T | I77N | 0.899 |
| 17:41047038:A:C | I77S | 0.897 |
| 17:41047002:C:G | C89S | 0.892 |
| 17:41047003:A:T | C89S | 0.892 |
| 17:41047031:G:C | C79W | 0.892 |
| 17:41046988:A:G | W94R | 0.880 |
| 17:41046988:A:T | W94R | 0.880 |
| 17:41047155:G:A | T38I | 0.877 |
| 17:41047018:A:G | C84R | 0.872 |
| 17:41047054:C:G | G72R | 0.872 |
| 17:41047028:G:C | C80W | 0.870 |
| 17:41046991:A:G | C93R | 0.867 |
| 17:41046989:G:C | C93W | 0.862 |
| 17:41046992:G:C | C92W | 0.859 |
| 17:41046996:G:T | P91H | 0.857 |
| 17:41047048:A:G | C74R | 0.854 |
| 17:41047051:A:G | C73R | 0.853 |
| 17:41047079:G:C | C63W | 0.848 |
| 17:41047046:G:C | C74W | 0.842 |
| 17:41046999:C:A | R90M | 0.841 |
| 17:41047067:G:C | C67W | 0.837 |
| 17:41047081:A:G | C63R | 0.837 |
| 17:41047032:C:T | C79Y | 0.835 |
dbSNP variants (sampled 300 via entrez): RS1000840289 (17:41047125 G>C), RS1002838622 (17:41049188 T>G), RS1005526399 (17:41049171 C>T), RS1005654424 (17:41047343 C>A,G,T), RS1006032495 (17:41048798 C>A,T), RS1006086508 (17:41049064 G>A), RS1006377094 (17:41046525 T>A,C,G), RS1007061681 (17:41046267 T>C), RS1007822064 (17:41047450 T>C,G), RS1008376336 (17:41048791 A>G), RS1008639179 (17:41047102 C>A), RS1009080942 (17:41048548 A>G), RS1009588202 (17:41047179 C>T), RS1009826706 (17:41048503 G>T), RS1011062649 (17:41046523 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects expression, decreases expression | 2 |
| Benzo(a)pyrene | affects methylation | 2 |
| Ethinyl Estradiol | affects expression, decreases expression | 2 |
| Smoke | increases expression | 2 |
| tricetin | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Curcumin | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Rotenone | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.